Physician profile
Dustin D Constant
NPI 1205221736
$51,368.08
in general payments reported to CMS, 2019-2025
30 companies · $28K in 2025
The $28K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,671 · 2020: $478 · 2021: $3,004 · 2022: $3,286 · 2023: $1,721 · 2024: $6,636 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $11K · Royalty Or License: $4,584 · Food and Beverage: $4,237.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,000.00 |
| Travel and Lodging | $11,107.55 |
| Royalty Or License | $4,584.09 |
| Food and Beverage | $4,236.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $19,393.78 | 2024-2025 | Biobrace 23mm, Hercules Suture Anchor System, Quantum |
| Arthrex, INC. | $8,392.02 | 2019-2023 | Distal Extremities Implants Foot & Ankle Metal Compression Screws |
| Gramercy Extremity Orthopedics LLC | $8,061.07 | 2021-2025 | |
| Theramicro, INC. | $6,128.06 | 2025 | Tekbrace Solo, Allostat Gfx |
| Vilex LLC | $2,805.87 | 2024 | |
| Orthofix Medical, INC. | $1,691.24 | 2019-2020 | |
| Stryker Corporation | $961.67 | 2019-2025 | Infinity, Ortholoc 3di, Mako |
| International Life Sciences | $934.69 | 2024 | Flexband |
| Celularity INC. | $765.70 | 2019-2020 | |
| Treace Medical Concepts, INC. | $664.95 | 2024-2025 | |
| Kerecis Limited | $243.91 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bone Support INC. | $193.74 | 2025 | Cerament G, Ceramentbone Void Filler |
| Bioventus LLC | $141.18 | 2021-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Voom Medical Devices, INC. | $125.49 | 2025 | Revcon, Revcon Instrument Kit, Sterile |
| Depuy Synthes Sales INC. | $110.71 | 2020-2025 | Va-Lcp |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenex Health INC. | $105.87 | 2021 | |
| Southern Edge Orthopaedics, INC. | $105.57 | 2025 | |
| Smith+Nephew, INC. | $103.49 | 2020-2025 | Pico 14, Renasys Touch, "Acticoat 4"" X 4""" |
| Musculoskeletal Transplant Foundation INC. | $95.94 | 2022 | |
| Amgen INC. | $81.04 | 2024 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $62.29 | 2025 | Tapestry |
| Ermi LLC | $50.63 | 2019-2024 | |
| Djo, LLC | $35.69 | 2020 | |
| Electronic Waveform Lab, INC. | $19.78 | 2020-2024 | |
| Flower Orthopedics Coporation | $18.78 | 2024 | |
| Embody, INC. | $18.62 | 2021 | |
| Novastep INC. | $16.29 | 2021 | |
| Paratek Pharmaceuticals, INC. | $15.24 | 2024 | Nuzyra |
| Horizon Therapeutics Plc | $13.98 | 2021 | |
| Sientra, INC. | $10.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Constant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.